Skip to content

AMICUS THERAPEUTICS, INC.

CIK 0001178879

← back to feed
Revenue (TTM)
$590.52M
+20.0% YoY FY Feb 2026
Net Income (TTM)
−$35.53M
+51.7% YoY FY Feb 2026
EPS Diluted (TTM)
−$0.11
+50.0% YoY FY Feb 2026
Gross Margin
89.9%
FY Feb 2026
Operating Margin
6.5%
FY Feb 2026
Net Margin
-6.0%
FY Feb 2026
Free Cash Flow (TTM)
−$103.16M
FY Feb 2026
Cash
$214.01M
FY Feb 2026
Total Debt
$392.66M
FY Feb 2026
Shares Outstanding
314M sh
FY Feb 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings